Astoria Strategic Wealth’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,428
Closed -$95K 31
2021
Q2
$95K Hold
10,428
0.04% 30
2021
Q1
$101K Hold
10,428
0.05% 29
2020
Q4
$75K Hold
10,428
0.04% 29
2020
Q3
$61K Hold
10,428
0.04% 28
2020
Q2
$48K Hold
10,428
0.03% 26
2020
Q1
$37K Hold
10,428
0.03% 31
2019
Q4
$86K Buy
+10,428
New +$75.3K 0.06% 32

Other funds holding APYX

Astoria Strategic Wealth's APYX Position: Q3 2021 in Review

Astoria Strategic Wealth sold out of Apyx Medical (APYX) in Q3 2021, closing a stake of 10,428 shares — an estimated $95K sold.

Astoria Strategic Wealth first reported a position in APYX in Q4 2019 and held it in 7 quarters. The position peaked at $101K in Q1 2021. 74 funds tracked by Wall St. Rank hold APYX as of Q3 2021.

  • Astoria Strategic Wealth reported no remaining Apyx Medical position as of Q3 2021 after selling out during the quarter.
  • Astoria Strategic Wealth sold 10,428 Apyx Medical shares in Q3 2021, an estimated $95K.
  • Astoria Strategic Wealth first reported a position in Apyx Medical in Q4 2019 and held it in 7 quarters.
  • Astoria Strategic Wealth's Apyx Medical position peaked at $101K in Q1 2021.
  • 74 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2021.

Based on Astoria Strategic Wealth's 13F filing for Q3 2021, filed 15 Nov 2021.